Generic Restasis is used to treat chronic dry eye by reducing inflammation in the tear gland. "The launch of cyclosporine ophthalmic emulsion reflects Upsher-Smith's continued momentum in expanding ...

These are single-use vials and should be discarded after each use.For questions about ordering, please call Upsher-Smith at 1-800-654-2299. About BoraFounded in 2007, Bora Pharmaceuticals ("Bora" or ...

Cyclosporine ophthalmic emulsion 0.05% is a topical immunomodulator indicated to increase tear production in patients with dry eye syndrome. Cyclosporine ophthalmic emulsion 0.05% is a topical ...

The US Food and Drug Administration (FDA) on Wednesday denied Allergan's third citizen petition attempting to block the agency from approving generic versions of the company's blockbuster Restasis ...

(RTTNews) - Amneal Pharmaceuticals, Inc. (AMRX) on Tuesday announced that the U.S. Food and Drug Administration has approved its cyclosporine ophthalmic emulsion 0.05%, a sterile formulation supplied ...

Please provide your email address to receive an email when new articles are posted on . At SkyVision, we have found that generic cyclosporine A 0.05% in a lipid emulsion is not a prescription that can ...

Cequa (cyclosporine) and Restasis (cyclosporine) are prescription drugs used to treat chronic (long-term) dry eye. Both drugs come as an eye drop you use twice per day. This article explains the main ...

DEAR DR. ROACH: My wife, who's 72, has had very dry eyes for a long time, so she uses Restasis (cyclosporine emulsion 0.05%) eye drops. Her co-pay (after meeting the deductible) last year was around ...

DEAR DR. ROACH: My wife, who's 72, has had very dry eyes for a long time, so she uses Restasis (cyclosporine emulsion 0.05%) eye drops. Her co-pay (after meeting the deductible) last year was around ...

WASHINGTON (Reuters) - Shares of Allergan Inc fell 12 percent on Monday after U.S. regulators issued draft guidance that would enable generic versions of the company's dry eye drug Restasis to come to ...

MAPLE GROVE, Minn., May 20, 2026 /PRNewswire/ -- Upsher-Smith Laboratories, LLC (Upsher-Smith), a subsidiary of Bora Pharmaceuticals Co., Ltd. (6472.TW and BORAY.OTCQX), today announced the recent ...